CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu
Cancer Research and Treatment. 2020;52(4):1059-1066.   Published online 2020 April 24    DOI: https://doi.org/10.4143/crt.2019.633

Excel Download

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study
Cancer Medicine. 2020;9(9):2981-2988   Crossref logo
Link1 Link2 Link3 Link4

HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
AboutOpen. 2018;4(1):59-61   Crossref logo
Link1 Link2

Pyrotinib versus lapatinib in HER2-positive breast cancer
The Lancet Oncology. 2019;20(10):e562   Crossref logo
Link1 Link2

HER2-positive breast cancer with brain metastasis: long-lasting response after lapatinib treatment
AboutOpen. 2018;4(1):32-34   Crossref logo
Link1 Link2

Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea
BMC Cancer. 2012;12(1):   Crossref logo
Link1 Link2 Link3

Pyrotinib in HER2-Positive local advanced or metastatic breast cancer patients: Results from a retrospective study in real-world setting
European Journal of Cancer. 2020;138:S58   Crossref logo
Link1 Link2

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
Breast Cancer: Targets and Therapy. 2014;37   Crossref logo
Link1

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
Breast Cancer: Targets and Therapy. 2012;35   Crossref logo
Link1

Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study
Breast Cancer. 2013;22(2):192-200   Crossref logo
Link1 Link2 Link3

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy
Cancer. 2011;117(21):5013-5020   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.